EPDR1 Promotes PD-L1 Expression and Tumor Immune Evasion by Inhibiting TRIM21-dependent Ubiquitylation of IkappaB Kinase-Β

Xiaoyu Qian,Jin Cai,Yi Zhang,Shengqi Shen,Mingjie Wang,Shengzhi Liu,Xiang Meng,Junjiao Zhang,Zijian Ye,Shiqiao Qiu,Xiuying Zhong,Ping Gao

DOI: https://doi.org/10.1038/s44318-024-00201-6

2024-01-01

Abstract:While immune checkpoint blockade (ICB) has shown promise for clinical cancer therapy, its efficacy has only been observed in a limited subset of patients and the underlying mechanisms regulating innate and acquired resistance to ICB of tumor cells remain poorly understood. Here, we identified ependymin-related protein 1 (EPDR1) as an important tumor-intrinsic regulator of PD-L1 expression and tumor immune evasion. Aberrant expression of EPDR1 in hepatocellular carcinoma is associated with immunosuppression. Mechanistically, EPDR1 binds to E3 ligase TRIM21 and disrupts its interaction with IkappaB kinase-b, suppressing its ubiquitylation and autophagosomal degradation and enhancing NF-kappa B-mediated transcriptional activation of PD-L1. Further, we validated through a mouse liver cancer model that EPDR1 mediates exhaustion of CD8+ T cells and promotes tumor progression. In addition, we observed a positive correlation between EPDR1 and PD-L1 expression in both human and mouse liver cancer samples. Collectively, our study reveals a previously unappreciated role of EPDR1 in orchestrating tumor immune evasion and cancer progression. PD-L1 is a key immune checkpoint and largely affects the response of patients to immunotherapy. This study identifies ependymin-related protein 1 (EPDR1) as a potent regulator of PD-L1 expression in hepatocellular carcinoma (HCC), facilitating immune evasion.Aberrant expression of EPDR1 in HCC is associated with immunosuppression.Tumor-intrinsic EPDR1 facilitates immune evasion by increasing anti-tumor CD8 + T cells exhaustion.EPDR1 enhances the NF-kappa B pathway and elevates PD-L1 expression in cancer cells by interfering with TRIM21-dependent degradation of IkappaB kinase-b.EPDR1-TRIM21-PD-L1 axis promotes tumor immune evasion in HCC. A tumor-intrinsic EPDR1-TRIM21-PD-L1 axis promotes CD8 + T cells exhaustion in liver cancer.